Science37: Using Technology To Enable Remote, Clinical Trials, with Belinda Tan
socalTECH
MAY 8, 2017
The company is backed by more than $67M in funding from such investors as Glynn Capital Management, GV (formerly Google Ventures), Amgen Ventures, Lux Capital, Redmile Group, dRx Capital (a Qualcomm and Novartis joint investment company), and Sanofi Ventures. What is Science37? One of the major barriers to finding patients is geography.
133 
Let's personalize your content